Tricuspid / Pulmonary valve

The development and successful results of transcatheter aortic valve implantation, followed by transcatheter therapies for mitral valve disease have opened a myriad of opportunities for transcatheter treatment of TR. Read this State-of-the-Art paper published in EuroIntervention by the PCR Tricuspid Focus Group.

Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.

The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.

Alessandro Sticchi interviews Susheel Kodali, PI of the TRISCEND trial, presented at TCT 2021. They discuss the main results of the study, its impact on the field of Tricuspid and the upcoming TRISCEND II study.

Discover the replay of this PCR Webinar on tricuspid valve disease with F. Maisano, R. von Bardeleben, J. L. Zamorano, J. Cavalcante, P. Lurz and G. Nickenig. Learn about transcatheter tricuspid valve procedures, and more!

Watch this session to discover various interesting cases on valvular disease, such as the implantation of a transcatheter aortic VIV for an acute AR in prior bio Bentall operation, the percutaneous pulmonic balloon valvuloplasty in a carcinoid pulmonic stenosis, as well as the percutaneous valve-in-valve in the...

Discover in this session a new strategy for the treatment of tricuspid regurgitation that can be an excellent alternative option to conventional treatment by studying it in a real situation, on a concrete case.

PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky

Mirvat Alasnag interviews Alec Vahanian on the Essentials of the 2021 ESC/EACTS Guidelines on Valvular Heart Diseases.

There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...